The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Disease Testing & Diagnostics Market Research Report 2024
Synopsis
Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
The global Respiratory Disease Testing & Diagnostics market was valued at US$ 4530.3 million in 2023 and is anticipated to reach US$ 5165.8 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Disease Testing & Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disease Testing & Diagnostics.
Report Scope
The Respiratory Disease Testing & Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Disease Testing & Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Disease Testing & Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Disease Testing & Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
The global Respiratory Disease Testing & Diagnostics market was valued at US$ 4530.3 million in 2023 and is anticipated to reach US$ 5165.8 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Disease Testing & Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disease Testing & Diagnostics.
Report Scope
The Respiratory Disease Testing & Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Disease Testing & Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Disease Testing & Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Disease Testing & Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Blood Gas Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Respiratory Disease Testing & Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Clinical Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disease Testing & Diagnostics Market Perspective (2019-2030)
2.2 Respiratory Disease Testing & Diagnostics Growth Trends by Region
2.2.1 Global Respiratory Disease Testing & Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Respiratory Disease Testing & Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Respiratory Disease Testing & Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Respiratory Disease Testing & Diagnostics Market Dynamics
2.3.1 Respiratory Disease Testing & Diagnostics Industry Trends
2.3.2 Respiratory Disease Testing & Diagnostics Market Drivers
2.3.3 Respiratory Disease Testing & Diagnostics Market Challenges
2.3.4 Respiratory Disease Testing & Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Disease Testing & Diagnostics Players by Revenue
3.1.1 Global Top Respiratory Disease Testing & Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Respiratory Disease Testing & Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Disease Testing & Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Disease Testing & Diagnostics Revenue
3.4 Global Respiratory Disease Testing & Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Disease Testing & Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disease Testing & Diagnostics Revenue in 2023
3.5 Respiratory Disease Testing & Diagnostics Key Players Head office and Area Served
3.6 Key Players Respiratory Disease Testing & Diagnostics Product Solution and Service
3.7 Date of Enter into Respiratory Disease Testing & Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Disease Testing & Diagnostics Breakdown Data by Type
4.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Type (2025-2030)
5 Respiratory Disease Testing & Diagnostics Breakdown Data by Application
5.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Respiratory Disease Testing & Diagnostics Market Size (2019-2030)
6.2 North America Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Respiratory Disease Testing & Diagnostics Market Size by Country (2019-2024)
6.4 North America Respiratory Disease Testing & Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Disease Testing & Diagnostics Market Size (2019-2030)
7.2 Europe Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2019-2024)
7.4 Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Respiratory Disease Testing & Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Disease Testing & Diagnostics Market Size (2019-2030)
9.2 Latin America Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Respiratory Disease Testing & Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Detail
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Respiratory Disease Testing & Diagnostics Introduction
11.1.4 Becton Dickinson Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.1.5 Becton Dickinson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Respiratory Disease Testing & Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Disease Testing & Diagnostics Introduction
11.3.4 Abbott Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Cepheid
11.4.1 Cepheid Company Detail
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Respiratory Disease Testing & Diagnostics Introduction
11.4.4 Cepheid Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.4.5 Cepheid Recent Development
11.5 Fischer and Paykel
11.5.1 Fischer and Paykel Company Detail
11.5.2 Fischer and Paykel Business Overview
11.5.3 Fischer and Paykel Respiratory Disease Testing & Diagnostics Introduction
11.5.4 Fischer and Paykel Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.5.5 Fischer and Paykel Recent Development
11.6 Futuremed
11.6.1 Futuremed Company Detail
11.6.2 Futuremed Business Overview
11.6.3 Futuremed Respiratory Disease Testing & Diagnostics Introduction
11.6.4 Futuremed Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.6.5 Futuremed Recent Development
11.7 Hoffmann-La Roche
11.7.1 Hoffmann-La Roche Company Detail
11.7.2 Hoffmann-La Roche Business Overview
11.7.3 Hoffmann-La Roche Respiratory Disease Testing & Diagnostics Introduction
11.7.4 Hoffmann-La Roche Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.7.5 Hoffmann-La Roche Recent Development
11.8 Instrumentation Laboratories
11.8.1 Instrumentation Laboratories Company Detail
11.8.2 Instrumentation Laboratories Business Overview
11.8.3 Instrumentation Laboratories Respiratory Disease Testing & Diagnostics Introduction
11.8.4 Instrumentation Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.8.5 Instrumentation Laboratories Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Respiratory Disease Testing & Diagnostics Introduction
11.9.4 Medtronic Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.9.5 Medtronic Recent Development
11.10 NDD Medical Technologies
11.10.1 NDD Medical Technologies Company Detail
11.10.2 NDD Medical Technologies Business Overview
11.10.3 NDD Medical Technologies Respiratory Disease Testing & Diagnostics Introduction
11.10.4 NDD Medical Technologies Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.10.5 NDD Medical Technologies Recent Development
11.11 Nihon Kohden
11.11.1 Nihon Kohden Company Detail
11.11.2 Nihon Kohden Business Overview
11.11.3 Nihon Kohden Respiratory Disease Testing & Diagnostics Introduction
11.11.4 Nihon Kohden Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.11.5 Nihon Kohden Recent Development
11.12 Philips Medical Systems
11.12.1 Philips Medical Systems Company Detail
11.12.2 Philips Medical Systems Business Overview
11.12.3 Philips Medical Systems Respiratory Disease Testing & Diagnostics Introduction
11.12.4 Philips Medical Systems Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.12.5 Philips Medical Systems Recent Development
11.13 SDI Diagnostics
11.13.1 SDI Diagnostics Company Detail
11.13.2 SDI Diagnostics Business Overview
11.13.3 SDI Diagnostics Respiratory Disease Testing & Diagnostics Introduction
11.13.4 SDI Diagnostics Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.13.5 SDI Diagnostics Recent Development
11.14 Seegene
11.14.1 Seegene Company Detail
11.14.2 Seegene Business Overview
11.14.3 Seegene Respiratory Disease Testing & Diagnostics Introduction
11.14.4 Seegene Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.14.5 Seegene Recent Development
11.15 Smiths Medical
11.15.1 Smiths Medical Company Detail
11.15.2 Smiths Medical Business Overview
11.15.3 Smiths Medical Respiratory Disease Testing & Diagnostics Introduction
11.15.4 Smiths Medical Revenue in Respiratory Disease Testing & Diagnostics Business (2019-2024)
11.15.5 Smiths Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
